Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Feb 2026 for Rocket Pharmaceuticals, INC..
Filing timeline
BuySaleSyed Ali-aamir Rizvi
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Syed Ali-aamir Rizvi: trading record in brief
Syed Ali-aamir Rizvi is a declared insider at 3 companies (senior executive); the most frequent names are Rocket Pharmaceuticals, Inc., Caribou Biosciences, Inc. and Poseida Therapeutics, Inc. We count 7 filings; the first trade dates from 25 January 2022 and the latest from 11 February 2026.
Every open-market trade on record is a sale: 1 sale worth €33k. Besides market trades, the filings include 5 share grants.
The newest entry dates from 13 February 2026: a share grant, in Rocket Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Syed Ali-aamir Rizvi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
61,963 shares0Common StockSEC:0001140361-26-005409:0
283,018 shares0Common StockSEC:0001140361-25-037683:0
185,000 sharesCommon StockSEC:0001415889-25-001083:0
185,000 shares0Common StockSEC:0000950170-24-041039:0
5,627 shares@ US$6.31100.0% of flowCommon StockSEC:0001619856-23-000002:0
60,000 shares0Common stockSEC:0001209191-22-004860:0
6 of 6 declarations
